PTC Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell PTCT and other ETFs, options, and stocks.

About PTCT

PTC Therapeutics, Inc. is a biopharmaceutical company, which focuses on the discovery, development, and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. The company was founded by Allan Steven Jacobson and Stuart Walter Peltz on March 31, 1998 and is headquartered in Warren, NJ.

CEO

Matthew B. Klein

CEOMatthew B. Klein

Employees

939

Employees939

Headquarters

Warren, New Jersey

HeadquartersWarren, New Jersey

Founded

1998

Founded1998

Employees

939

Employees939

PTCT Key Statistics

Market cap

3.65B

Market cap3.65B

Price-Earnings ratio

7.07

Price-Earnings ratio7.07

Dividend yield

—

Dividend yield—

Average volume

2.31M

Average volume2.31M

High today

$46.19

High today$46.19

Low today

$44.04

Low today$44.04

Open price

$45.37

Open price$45.37

Volume

1.50M

Volume1.50M

52 Week high

$58.38

52 Week high$58.38

52 Week low

$28.72

52 Week low$28.72

PTCT News

TipRanks 6d

PTC Therapeutics: Strategic Growth and Market Expansion Drive Buy Rating

PTC Therapeutics (PTCT – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Eric Joseph from J.P. Morgan mai...

Simply Wall St 6d

Solid Earnings Reflect PTC Therapeutics' Strength As A Business

PTC Therapeutics, Inc. ( ) recently posted some strong earnings, and the market responded positively. Our analysis found some more factors that we think are goo...

Analyst ratings

63%

of 16 ratings

Buy

62.5%

Hold

31.3%

Sell

6.3%

People also own

Based on the portfolios of people who own PTCT. This list is generated using Robinhood data, and it’s not a recommendation.